Mathematically-OptimiZed Risk Evaluation Kim A

Slides:



Advertisements
Similar presentations
Module 1 Evaluation Overview © Crown Copyright (2000)
Advertisements

Day to Day Management of Quality Control
Statistical Issues in Research Planning and Evaluation
POC INR Testing Rural and Remote Session 2015 CADTH SYMPOSIUM Janice Mann MD Knowledge Mobilization, CADTH.
Interpreting Your Lab Report & Quality Control Results
Chapter 13: Audit Sampling Spring Overview of Sampling.
Quality Assurance.
CDRH Review Practice for Over-the-Counter in Vitro Diagnostic Tests
Utilization of Assay Performance Characteristics to Estimate Hemoglobin A 1c Result Reliability A. Woodworth, N. Korpi-Steiner, J.J. Miller, L.V. Rao,
Internal Quality Control (QC) for Medical Laboratories: An introduction Dr. Otto Panagiotakis and Dr. Alexander Haliassos ESEAP – Greek Proficiency Testing.
Laboratory Management - 1
This teaching material has been made freely available by the KEMRI-Wellcome Trust (Kilifi, Kenya). You can freely download,
InterQC Delivering Simplicity in the Quality Control Management for your Laboratory Developed by Vitro.
Quality Assurance.
Quality Assessment 2 Quality Control.
Debbie Moosa Thistle QA. Quality Management involves philosophy, principles, methodology, techniques, tools and metrics. Six Sigma can be considered as.
BASIC STATISTICS: AN OXYMORON? (With a little EPI thrown in…) URVASHI VAID MD, MS AUG 2012.
Performance Measurement and Analysis for Health Organizations
Increasing Pharmacists reporting of adverse medication incidents Being Ready for new risks and Opportunities Prepared by Tim Garrett Northern Sydney Central.
Preventing Surgical Complications Prevent Harm from High Alert Medication- Anticoagulants in Primary Care Insert Date here Presenter:
HD 2007 Rule Diesel Fuel Sulfur Testing and Sampling Methods and Requirements US EPA Office of Transportation and Air Quality November 20, 2002.
Automated CBC Parameters
Quality Control and Patient Risk Curtis A. Parvin, Ph. D
Laboratory QA/QC An Overview.
Biostatistics Class 6 Hypothesis Testing: One-Sample Inference 2/29/2000.
Module 2: Quality and Quality Measures The degree to which health services for individuals and populations increase the likelihood of desired health outcomes.
Sample Size Considerations for Answering Quantitative Research Questions Lunch & Learn May 15, 2013 M Boyle.
Why do we need to do it? What are the basic tools?
Chapter 10: Measurement Slavin Reliability & Validity Types of Measures Behavioral Observation Systems Sample Size Determination.
Verification of qualitative methods
QC/QA.
Assessing Responsiveness of Health Measurements Ian McDowell, INTA, Santiago, March 20, 2001.
Control Charts and Trend Analysis for ISO 17025
Quality Control Internal QC External QC. -Monitors a test's method precision and analytical bias. -Preparation of quality control samples and their interpretation.
 Remember Chemistry panel Quality Control:-  In a medical laboratory, it is a statistical process used to monitor and evaluate the analytical process.
Westgard Multirule System
 Routine viral diagnostics: indirect and direct detection of viruses. ◦ Indirect detection: serological tests; ◦ Direct detection:  Viral antigens;
Computerized Physician Order Entry (CPOE), Process, Costs and Benefits Joe Shaffer, MS Alberto Coustasse, DrPH, MD Graduate School of Management, College.
Examination Results Dr. W. Huisman Cairo, November 21th 2012.
Patient Safety Monitoring in International Laboratories (SMILE) Mark Swartz, MT(ASCP), SMILE QA/QC Coordinator Improving the Sensitivity of QC Monitoring:
HuQAS Proficiency testing Scheme - A necessity in continuous quality improvement Michael Kamiru
Diagnostic clinical chemistry
Introduction to Quality Assurance. Quality assurance vs. Quality control.
Quality Assurance.
Quality Assessment.
Decision Making We could use two films here, so we want lots of extra time. What to cut out? Dangerous minds is good hopefully for expectancy and equity.
Audit Sampling: An Overview and Application to Tests of Controls
“Quality Improvement – Who Cares?”
QUALITY MANAGEMENT Suzanne Kamel-Mohamed PhD, MBA, MT (ASCP) Associate
Pakistan Society Of Chemical Pathologists Zoom Series of Lectures ZT 24. Quality Managent 1 Brig Aamir Ijaz MCPS, FCPS, FRCP (Edin), MCPS-HPE HOD and.
Risk Communication in Medicines
CLINICAL PROTOCOL DEVELOPMENT
Quality Healthcare for Everyone
BAYESIAN THEORY WITH ADAPTIVE METHOD OR DOSING WITH FEEDBACK
Risk Management 5- 6 November 2017 Regency Hotel, Kuwait Carlo Kaabar
MIS5101: Business Intelligence Outcomes Measurement and Data Quality
Practical clinical chemistry
PMI North Area PMP Exam Study Group
مدیریت داده ها و اطلاعات آزمایشگاه پزشکی
What it Means, Why it Works, and How to Comply
Process control in Hematology section
Topics in Microbiology Quality Assurance Project Plan Essentials
Why Use Them? By: Marcy Bolek – Alloway
Using statistics to evaluate your test Gerard Seinhorst
Unit 1: Reliability of Measurements
Introduction To Medical Technology
Quality Control Lecture 3
▪Internal quality control:
Quality Assessment The goal of laboratory analysis is to provide the accurate, reliable and timeliness result Quality assurance The overall program that.
A New Concept for Laboratory Quality Management Systems
Presentation transcript:

Mathematically-OptimiZed Risk Evaluation Kim A Mathematically-OptimiZed Risk Evaluation Kim A. Przekop MBA MLS(ASCP)CM Zoe C. Brooks ART Awesome Numbers, Inc., Ontario, Canada Laboratories have used quality control (QC) concepts and theories based on the same statistical calculations and assumptions for decades. Risk management, as stated in Clinical & Laboratory Standards Institute’s (CLSI) EP23A Guideline, adds an 'acceptable risk criteria.' Now there is a way to comply with EP23A and also save time, reduce risk to patients, and diminish analytical lab errors and their costs. The Mathematically-OptimiZed Risk Evaluation™ (M.O.R.E.) method enhances existing QC concepts, while risk metrics unveil a wealth of new understanding - just 'beyond sigma.' M.O.R.E. is an Excel-based software that can consistently evaluate QC results and propel the QC process to meet locally-defined quality standards. The M.O.R.E. method begins with basic QC values: target and current mean, the QC chart mean, target and current SD, frequency of QC runs, and any QC rules applied. Then, the medical director and/or clinicians sets medical goals and acceptable risk levels for quantitative analytes, while the administrative director sets costs/test and the average cost of harm to the patient if a medically-unreliable result (MUR) is released from the laboratory for those analytes. Medical goals are similar to allowable error limits; however, clinicians set the goals with their patients in mind. The acceptable risk level drives the number of patients a laboratory is willing to expose to an MUR. Currently, SQC (Statistical QC) reports a numerical indicator of the level of quality which is subject to variations in calculation and interpretation. The new M.O.R.E. method answers the question, "Is risk acceptable?" with a clear "Yes" or "No." The M.O.R.E. method increases the effectiveness of the QC process and its ability to reduce the number of MURs, and also alerts the laboratorian immediately when the analytical process changes enough to allow more than the acceptable number of MURs to be released. Risk Drivers: The path to M.O.R.E. Example Start Here. Patient Results / Month 9,000 CARL: Current Acceptable Risk Level # MUR / YEAR 1 PARL: Potential Acceptable Risk Level # MUR / Day of Failure True Value (Peer Mean preferred, or package insert target) 100.0 Locally-Approved Medical Goal (or enter TEa limit to model) 30.0 Current Measured Mean 95.0 Current Measured SD 5.00 Existing Q.C. Chart Mean Existing Q.C. Chart SD 8.0 Existing QC Reject Rule 1- 3 QC sample frequency / Month 30 Estimated average cost/MUR $100.00 Cost/test for each QC or patient result $1.00 Risk evaluation -process of comparing the estimated risk against given risk criteria to determine the acceptability of the risk (ISO 14971) Verify QC Samples mirror Patients Define medical goals: Results must be within ___% or __ units to be considered 'relevant, accurate, and reliable for patient care'. Values beyond this range are 'Medically-Unreliable Results' or 'MURs.' Define acceptable risk criteria. Current Risk: Acceptable number and cost of MURs with routine accuracy & precision at regular (monthly) QC review - as MUR/year Potential Risk: Acceptable number and cost of MURs reported if the method fails unexpectedly – as MUR/day CARL – the locally-approved Current Acceptable Risk Level – defined as the acceptable number of medically-unreliable results (MURs) per year for each analyte/ analytical process and QC sample. CARL is typically set at 1 MUR/Year, replacing the statistical QC assumptions such as 5%, or 2 sigma (2.75% error), or 3 sigma (0.135% error). Auto-evlauate risk. Verify QCP Effectiveness. Assess current risk and cost in Software Report Convert verified risk drivers to the number, percent and cost of Medically Unreliable Results (MURs) C. Improve QCP Current Risk Level OK? Margin for Error Ability of the QCP to detect medically allowable error (TEa) PASS 0.72 Detect Failure in One Day? Avoidable False Pos? Existing QCP: Chart values, QC rule and frequency FAIL N/A   Mathematically-OptimiZed QC Process UNAVOIDABLE STOP Evaluate Current risk. Is current risk less than acceptable risk criteria? No Yes Assess potential risk and cost: Quantify number and cost of MURs reported following a simulated clinical failure – with both the existing and Mathematically-OptimiZed QC Processes. Evaluate Potential Risk and QC costs - with existing QC Process Is potential risk less than acceptable risk criteria? – Example of potential savings with M.O.R.E. Yes Quantify the impact of QC design on patient risk & clinical/legal cost   Existing M.O.R.E. Savings Difference in cost to control Quality / MONTH $30 $60 ($30) # Patients exposed to unacceptable Risk > simulated failure 6,000 300 5,700 # MUR before QC Flag = 20 1 19   If failure rate = 5.0% # MURs = 15 -285 Potential net healthcare saving, if method fails = $30,000 $1,500 $28,500 No  Acceptable Patient Risk Implement the Mathematically-OptimiZed QC Process This process is mathematically-calculated to meet acceptable potential risk. Apply chart mean & SD, QC rule and frequency Follow action flags to improve accuracy and/or precision Acceptable risk – “A state achieved in a measuring system where all known potential events have a degree of likelihood for or a level of severity of an adverse outcome small enough such that, when balanced against all known benefits— perceived or real—patients, physicians, institutions, and society are willing to risk the consequences.” CLSI EP23-A “At the least, the ability of the QC procedures to detect medically allowable error should be evaluated.” References: CLSI. Laboratory Quality Control Based on Risk Management; Guideline. CLSI document EP23 Wayne, PA: Clinical and Laboratory Standards Institute; 2011. Brooks Z. M.O.R.E. Quality: Lev 1. Risk Assessor. Worthington, ON: AWEsome Numbers Inc.; 2016 Contact Information: Kim: Crosswayzconsulting@gmail.com Zoe: Zoe@awesome-numbers.org Conflict of Interest Disclosure: Zoe Brooks is CEO and Director of Innovation and Research at AWEsome Numbers, Inc., and creator of the process of Mathematically-OptimiZed Risk Evaluation